Dr. Sacco is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3855 Health Sciences Drive
#0658
La Jolla, CA 92093Phone+1 858-822-5800Fax+1 858-822-5754
Education & Training
University of MichiganFellowship, Hematology and Medical Oncology, 2011 - 2014
Loyola University Medical CenterResidency, Internal Medicine, 2008 - 2011
Loyola University Chicago Stritch School of MedicineClass of 2008
Certifications & Licensure
CA State Medical License 2014 - 2026
MI State Medical License 2011 - 2014
IL State Medical License 2008 - 2011
Clinical Trials
- Pembrolizumab Combined With Cetuximab for Treatment of Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma Start of enrollment: 2017 Mar 28
- Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid Tumors Start of enrollment: 2018 Jun 25
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- 143 citationsPositive Surgical Margins in the 10 Most Common Solid CancersRyan K. Orosco, Viridiana J. Tapia, Joseph A. Califano, Bryan M. Clary, Ezra E.W. Cohen
Scientific Reports. 2018-04-09 - 30 citationsOropharyngoplasty with template-based reconstruction of oropharynx defects.Douglas B. Chepeha, Assuntina G. Sacco, Vanessa Erickson, Teresa Lyden, Marc J. Haxer
Archives of Otolaryngology--Head & Neck Surgery. 2009-09-01 - 155 citationsHypermutated Circulating Tumor DNA: Correlation with Response to Checkpoint Inhibitor-Based Immunotherapy.Yulian Khagi, Aaron M. Goodman, Gregory A. Daniels, Sandip Pravin Patel, Assuntina G. Sacco
Clinical Cancer Research. 2017-10-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
